drugset / Trial / NCT02973620

Levosimendan Compassionate Use in Pediatric Patients With Advanced Decompensated Heart Failure

NCT02973620

Expanded access No longer available Tenax Therapeutics, Inc.

Summary

Open label study of levosimendan; planned comparison for effectiveness and safety to historic matched case controls from participating sites.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Levosimendan Other / unclassified 0.2 ug/kg Other

Indications